Purchase Order 75N95022P00652

Award Date 9/20/22
Potential Completion Date 9/19/25
Potential Value $2.4M
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Austin, TX 78759, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health, National Institute of Neurological Disorders and Stroke awarded a $591,600 labor-hour contract to Toxstrategies, LLC to provide toxicology consulting services in support of the Helping to End Addiction Long-term Initiative and other neuroscience drug discovery programs. The contract is set aside for small businesses. Toxstrategies will provide a minimum of 20 hours annually of consulting services on Lead Development Teams, including evaluating chemical...
This federal contract award to Certara USA Inc. is for toxicology consulting services to support the National Institute of Neurological Disorders and Stroke (NINDS), the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN), the NIH Helping to End Addiction Long-term (HEAL) Initiative, and other NIH neuroscience-focused drug discovery and development programs. The $2,167,500.00 purchase order contract has a completion date of September 19, 2025 and is not a set-aside...
This is a $444,500.00 labor-hour federal contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to In Vitro Strategies Limited Liability Company, a woman-owned small business. The contract is for the provision of senior-level consultant support services for bioactivity assay development to support the NINDS Blueprint Neurotherapeutics Program and other NIH neuroscience-focused drug development...
This is a $244,800 contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to RPK Associates, LLC, a small business. The contract is for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products for NIH drug discovery and development programs, including the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics)...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency of the U.S. government, awarded a $4,947,189.56 purchase order contract to Voisin Consulting, Inc. for biological therapeutics subject matter expert (SME) consulting services. The contract is a total small business set-aside with a performance period from April 2022 through April 2025. The SMEs will provide technical recommendations and advice to support the translational development of novel biologics for...
This federal contract award, valued at $1,884,275.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pharmalex US Corporation for Biologics Subject Matter Expert (SME) Consulting Services. The contract is a total small business set-aside, with a period of performance through April 14, 2025. The award is in support of NINDS programs such as the Blueprint Neurotherapeutics Network Biologics (BPN-Biologics), the Ultra-Rare Gene Therapy...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $462,900.00 contract to The Conjugate Group LLC, a small disadvantaged business, to provide regulatory affairs consultant support services. The contract has a base period of one year beginning September 2023 with two optional one-year extensions. The services are in support of the NIH Blueprint Neurotherapeutics program and the NIH HEAL Pain Therapeutics Development Program, as well as other NINDS...
This is a $443,240.75 labor-hour purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Integrated Nonclinical Development Solutions Inc. (IND Solutions), a small business subchapter S corporation, to provide toxicology consultant support services for the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs. The contract is a 100% small business set-aside and...
This federal contract award to SRI International, a non-profit research and development institute, is for $1,469,307.00 to conduct rodent and non-rodent pharmacokinetic studies. The contract is a delivery order issued under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master IDIQ contract with the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The...
This is a delivery order awarded to Southern Research Institute by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency under the U.S. Department of Health and Human Services. The $619,541.19 cost-plus-fixed-fee contract is for pharmacokinetics and toxicology studies in support of the Pharmacology and Toxicology for Therapeutics Program (PTTP), an indefinite-delivery, indefinite-quantity (ID/IQ) contract vehicle. This contract has no set-aside designation....

This $2,370,000 federal contract was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Toxstrategies, LLC, a multidisciplinary scientific consulting firm based in Austin, Texas. The contract is for toxicology consulting services to support the NINDS, NIH Blueprint Neurotherapeutics Network (BPN), NIH Helping to End Addiction Long-term (HEAL) Initiative, and other NIH neuroscience-focused drug discovery and development programs. Toxstrategies will provide technical guidance from senior scientific experts with experience in the drug discovery and development process, with a particular focus on central nervous system and small molecule expertise. This contract does not have a set-aside designation and was competitively awarded. Toxstrategies has a history of providing similar consulting services to federal agencies like the Department of Justice, NIH, and Food and Drug Administration.

Generated 7/31/24, 9:07 AM